Cuál es el precio por Novo Nordisk A/S (NOVO-B)

Precio por Novo Nordisk A/S (NOVO-B) es de$41.14

Cuál es la capitalización de mercado por Novo Nordisk A/S (NOVO-B)

Capitalización de mercado por Novo Nordisk A/S (NOVO-B) es $182.76B

Novo Nordisk A/S (NOVO-B) Desdoblamientos de Acciones

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Año	Desdoblamiento	Multiplicador	Multiplicador acumulado
2023-09-20	2:1	x2	x200
2014-01-09	5:1	x5	x100
2007-12-17	2:1	x2	x20
2001-04-11	5:2	x2.5	x10
1994-04-18	4:1	x4	x4

Año

Desdoblamiento

Multiplicador

Multiplicador acumulado

2023-09-20

2:1

x200

2014-01-09

5:1

x100

2007-12-17

2:1

x20

2001-04-11

5:2

x2.5

x10

1994-04-18

4:1

Empresa	Número de desdoblamientos de acciones	Multiplicador acumulado	País
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

Empresa

Número de desdoblamientos de acciones

Multiplicador acumulado

País